

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in biologic therapy of asthma and... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-412/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-412" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis.">
            <meta name="og:description" content="Read the latest article version by Rohit Divekar, Devyani Lal, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="14286">
            <meta name="article-id" content="13170">
            <meta name="dc.title" content="Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis">
            <meta name="dc.description" content="Great strides have been made in the last five years in understanding the pathology of chronic rhinosinusitis (CRS). CRS is now accepted to be the end-stage manifestation of inflammation resultant from various pathogenetic mechanisms. This has resulted in increasing recognition of distinct CRS endotypes. Such endotypes encompass a cluster of patients with similar pathogenic mechanisms that may have common therapeutic targets and responsiveness to interventions. The elucidation of mechanisms leading to the development of chronic upper (sino-nasal) airway inflammation has to some extent paralleled investigations of aberrant pathways operant in asthma. In this review, we focus on recent developments in understanding the innate immune pathways as well as adaptive (late) immune responses in CRS and asthma and their implication as potentially modifiable targets in CRS. Specific biologic therapy (that is, monoclonal antibodies targeting cytokines, cytokine receptors, or specific key molecules targeting inflammation) is an exciting proposition for the future of medical management of CRS. As of the writing of this article, the agents described are not approved for use in CRS; many have partial approval for use in asthma or are considered experimental.">
            <meta name="dc.subject" content="sinusitis, biologics, nasal polyp,  rhinosinusitis">
            <meta name="dc.creator" content="Divekar, Rohit">
            <meta name="dc.creator" content="Lal, Devyani">
            <meta name="dc.date" content="2018/03/29">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.13170.1">
            <meta name="dc.source" content="F1000Research 2018 7:412">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="sinusitis">
            <meta name="prism.keyword" content="biologics">
            <meta name="prism.keyword" content="nasal polyp">
            <meta name="prism.keyword" content="rhinosinusitis">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/03/29">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="412">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.13170.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-412">
            <meta name="citation_title" content="Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis">
            <meta name="citation_abstract" content="Great strides have been made in the last five years in understanding the pathology of chronic rhinosinusitis (CRS). CRS is now accepted to be the end-stage manifestation of inflammation resultant from various pathogenetic mechanisms. This has resulted in increasing recognition of distinct CRS endotypes. Such endotypes encompass a cluster of patients with similar pathogenic mechanisms that may have common therapeutic targets and responsiveness to interventions. The elucidation of mechanisms leading to the development of chronic upper (sino-nasal) airway inflammation has to some extent paralleled investigations of aberrant pathways operant in asthma. In this review, we focus on recent developments in understanding the innate immune pathways as well as adaptive (late) immune responses in CRS and asthma and their implication as potentially modifiable targets in CRS. Specific biologic therapy (that is, monoclonal antibodies targeting cytokines, cytokine receptors, or specific key molecules targeting inflammation) is an exciting proposition for the future of medical management of CRS. As of the writing of this article, the agents described are not approved for use in CRS; many have partial approval for use in asthma or are considered experimental.">
            <meta name="citation_description" content="Great strides have been made in the last five years in understanding the pathology of chronic rhinosinusitis (CRS). CRS is now accepted to be the end-stage manifestation of inflammation resultant from various pathogenetic mechanisms. This has resulted in increasing recognition of distinct CRS endotypes. Such endotypes encompass a cluster of patients with similar pathogenic mechanisms that may have common therapeutic targets and responsiveness to interventions. The elucidation of mechanisms leading to the development of chronic upper (sino-nasal) airway inflammation has to some extent paralleled investigations of aberrant pathways operant in asthma. In this review, we focus on recent developments in understanding the innate immune pathways as well as adaptive (late) immune responses in CRS and asthma and their implication as potentially modifiable targets in CRS. Specific biologic therapy (that is, monoclonal antibodies targeting cytokines, cytokine receptors, or specific key molecules targeting inflammation) is an exciting proposition for the future of medical management of CRS. As of the writing of this article, the agents described are not approved for use in CRS; many have partial approval for use in asthma or are considered experimental.">
            <meta name="citation_keywords" content="sinusitis, biologics, nasal polyp,  rhinosinusitis">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Rohit Divekar">
            <meta name="citation_author_institution" content="Division of Allergic Diseases, Mayo Clinic, Rochester, USA">
            <meta name="citation_author" content="Devyani Lal">
            <meta name="citation_author_institution" content="Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Arizona, USA">
            <meta name="citation_publication_date" content="2018/03/29">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="412">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.13170.1">
            <meta name="citation_firstpage" content="412">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-412/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-412.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=14286 /> <input type=hidden id=articleId name=articleId value=13170 /> <input type=hidden id=xmlUrl value="/articles/7-412/v1/xml"/> <input type=hidden id=xmlFileName value="-7-412-v1.xml"> <input type=hidden id=article_uuid value=08d2aadd-c966-4996-aa28-08a9962a524c /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.13170.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.13170.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-412"
  },
  "headline": "Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis",
  "datePublished": "2018-03-29T14:51:15",
  "dateModified": "2018-03-29T14:51:15",
  "author": [
    {
      "@type": "Person",
      "name": "Rohit Divekar"
    },    {
      "@type": "Person",
      "name": "Devyani Lal"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Great strides have been made in the last five years in understanding the pathology of chronic rhinosinusitis (CRS). CRS is now accepted to be the end-stage manifestation of inflammation resultant from various pathogenetic mechanisms. This has resulted in increasing recognition of distinct CRS endotypes. Such endotypes encompass a cluster of patients with similar pathogenic mechanisms that may have common therapeutic targets and responsiveness to interventions. The elucidation of mechanisms leading to the development of chronic upper (sino-nasal) airway inflammation has to some extent paralleled investigations of aberrant pathways operant in asthma. In this review, we focus on recent developments in understanding the innate immune pathways as well as adaptive (late) immune responses in CRS and asthma and their implication as potentially modifiable targets in CRS. Specific biologic therapy (that is, monoclonal antibodies targeting cytokines, cytokine receptors, or specific key molecules targeting inflammation) is an exciting proposition for the future of medical management of CRS. As of the writing of this article, the agents described are not approved for use in CRS; many have partial approval for use in asthma or are considered experimental."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-412.html",
            "name": "Recent advances in biologic therapy of asthma and the role in therapy..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in biologic therapy of asthma and the role in therapy... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=14286 data-id=13170 data-downloads="" data-views="" data-scholar="10.12688/f1000research.13170.1" data-recommended="" data-doi="10.12688/f1000research.13170.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-412/v1/pdf?article_uuid=08d2aadd-c966-4996-aa28-08a9962a524c" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-13170-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-13170-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-13170-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Divekar R and Lal D. Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):412 (<a class=new-orange href="https://doi.org/10.12688/f1000research.13170.1" target=_blank>https://doi.org/10.12688/f1000research.13170.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-13170-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=13170 id=track-article-signin-13170 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/13170?target=/articles/7-412.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=14286 /> <input name=articleId type=hidden value=13170 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Rohit Divekar<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:lal.devyani@mayo.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Devyani Lal</span></a><a href="https://orcid.org/0000-0002-7593-2385" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-7593-2385</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Rohit Divekar<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:lal.devyani@mayo.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Devyani Lal</span></a><a href="http://orcid.org/0000-0002-7593-2385" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-7593-2385</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 29 Mar 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.13170.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Allergic Diseases, Mayo Clinic, Rochester, USA<br/> <sup>2</sup> Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Arizona, USA<br/> <p> <div class=margin-bottom> Rohit Divekar <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Devyani Lal <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=31919-32045></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=31918-32044></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Great strides have been made in the last five years in understanding the pathology of chronic rhinosinusitis (CRS). CRS is now accepted to be the end-stage manifestation of inflammation resultant from various pathogenetic mechanisms. This has resulted in increasing recognition of distinct CRS endotypes. Such endotypes encompass a cluster of patients with similar pathogenic mechanisms that may have common therapeutic targets and responsiveness to interventions. The elucidation of mechanisms leading to the development of chronic upper (sino-nasal) airway inflammation has to some extent paralleled investigations of aberrant pathways operant in asthma. In this review, we focus on recent developments in understanding the innate immune pathways as well as adaptive (late) immune responses in CRS and asthma and their implication as potentially modifiable targets in CRS. Specific biologic therapy (that is, monoclonal antibodies targeting cytokines, cytokine receptors, or specific key molecules targeting inflammation) is an exciting proposition for the future of medical management of CRS. As of the writing of this article, the agents described are not approved for use in CRS; many have partial approval for use in asthma or are considered experimental. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> sinusitis, biologics, nasal polyp, rhinosinusitis </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Devyani Lal (<a href="mailto:lal.devyani@mayo.edu">lal.devyani@mayo.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Devyani Lal </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Divekar R and Lal D. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Divekar R and Lal D. Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):412 (<a href="https://doi.org/10.12688/f1000research.13170.1" target=_blank>https://doi.org/10.12688/f1000research.13170.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 29 Mar 2018, <b>7</b>(F1000 Faculty Rev):412 (<a href="https://doi.org/10.12688/f1000research.13170.1" target=_blank>https://doi.org/10.12688/f1000research.13170.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 29 Mar 2018, <b>7</b>(F1000 Faculty Rev):412 (<a href="https://doi.org/10.12688/f1000research.13170.1" target=_blank>https://doi.org/10.12688/f1000research.13170.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d59526e159>Background</h2><p class="" id=d59526e162>Recent advances in the biologic therapy of asthma and the potential role of these biologics for chronic rhinosinusitis (CRS) therapy are the focus of this review. Currently, no biologic therapy is US Food and Drug Administration (FDA)-approved for use in CRS. However, possible FDA approval in the future and ongoing off-label use are reasons for studying the potential role and indications of biologic therapy in CRS. Intranasal corticosteroids, systemic corticosteroids, antibiotics, and saline irrigations are currently employed for managing CRS<sup><a href="#ref-1">1</a></sup>. These are effective and generally safe and cheaper alternatives to biologics, however for patients with recalcitrant CRS that has not responded to conventional medical and surgical therapy, biologic therapy has promise. Our foremost challenge, however, is in identifying these subjects. The use of biological therapies which target specific inflammatory mediators (that is, based on endotypes) beyond phenotypes is well recognized in asthma<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. The concept of endotypes is increasingly being discussed in clinical contexts for managing CRS<sup><a href="#ref-4">4</a>,<a href="#ref-5">5</a></sup>. In the following text, we will discuss specific biologic drugs, their current role in asthma therapy, and their potential role in managing subsets of patients with CRS. A full discussion of CRS endotypes is beyond the scope of this review, but we will highlight subsets of CRS patients who may be most suitable candidates for each biologic therapy.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d59526e186>Epithelium-derived immune pathways and potential targets</h2><p class="" id=d59526e189>Epithelium-derived inflammatory cytokines such as thymic stromal lymphopoietin (TSLP) and interleukin-33 (IL-33) are novel cytokines thought to function as ‘<i>alarmins</i>’ and are implicated in type 2 helper (Th2)-like inflammatory processes<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. Their role in CRS has recently been described in conjunction with innate lymphoid cell type 2 (ILC2) cells or eosinophils, both cell types thought to be involved in the pathology of CRS<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. Buchheit <i>et al</i>. report that in aspirin exacerbated respiratory disease (AERD), a subtype of CRS/asthma which manifests with recurrent polyposis, CRS, asthma, and non-steroidal anti-inflammatory drug (NSAID) sensitivity, TSLP also drove prostaglandin D<sub>2</sub> (PGD<sub>2</sub>) production from mast cells and was increased in active form in local polyp tissue, thus contributing to the inflammatory cascade<sup><a href="#ref-10">10</a></sup>. In another study, Liao <i>et al</i>. show that increased expression of TSLP and its receptor (TSLP-R) in eosinophilic CRS with nasal polyps (CRSwNP) correlates with increased Th2 cytokine expression in sino-nasal mucosa<sup><a href="#ref-11">11</a></sup>. Since TSLP is considered an “upstream” activator of inflammation, TSLP seems to be an attractive target for therapy in CRS. Tezepelumab, a monoclonal antibody blocking TSLP, is currently in clinical trials for asthma (ClinicalTrials.gov identifiers NCT02054130 and NCT02698501) and atopic dermatitis (ClinicalTrials.gov identifier NCT02525094)<sup><a href="#ref-12">12</a></sup>. A recent clinical study reported tezepelumab to be beneficial in reducing rates of asthma exacerbations in “difficult to control” asthma. Moreover, subjects undergoing TSLP blockade in the study showed significant reduction in peripheral eosinophil counts and serum IgE<sup><a href="#ref-13">13</a></sup>. Given the parallels with eosinophilic CRS where elevated peripheral eosinophil counts and total IgE are also seen, the clinical efficacy of TSLP blockade may have potential therapeutic implications to treat this subtype of disease. </p><p class="" id=d59526e238>IL-33 is an epithelial-derived cytokine with a broad range of effects on innate as well as adaptive immune response and induces Th2 type inflammation<sup><a href="#ref-6">6</a>,<a href="#ref-14">14</a>–<a href="#ref-16">16</a></sup>. IL-33 was shown to be increased in sinus mucosal samples of eosinophilic CRS patients undergoing surgery<sup><a href="#ref-17">17</a></sup>, whereas another study demonstrated that epithelial cells of both eosinophilic and non-eosinophilic CRS had greater IL-33 compared with controls<sup><a href="#ref-11">11</a></sup>. The broad effects on the downstream inflammatory cascade<sup><a href="#ref-18">18</a></sup> and the fact that IL-33 may be elevated in both eosinophilic and non-eosinophilic inflammation in CRS make it an attractive target. IL-33-responsive ILC2 cells were shown to be an important source of IL-13 in CRSwNP<sup><a href="#ref-19">19</a></sup>. IL-33 also acts on other cell types such as mast cells<sup><a href="#ref-20">20</a></sup>, dendritic cells<sup><a href="#ref-21">21</a></sup>, Th2 cells, immature natural killer (iNK) and NK cells, basophils<sup><a href="#ref-18">18</a></sup>, and eosinophils<sup><a href="#ref-22">22</a></sup>. Abrogation of IL-33 signaling using anti-IL-33 antibody reduced mucosal edema, sub-epithelial tissue collagen deposition, and neutrophil infiltration in a murine model of CRS induced with staphylococcal enterotoxin B<sup><a href="#ref-23">23</a></sup>. <i>Staphylococcal aureus</i> and its enterotoxin induce local and systemic inflammatory changes and are thought to be involved in a pathologic role in the development of human CRS<sup><a href="#ref-24">24</a></sup> as well. Thus, blockade of IL-33 activity by reducing its release or its effect on effector cells would be of potential benefit. Studies investigating anti-ST2 monoclonal antibodies inhibiting binding of IL-33 to its receptor (ST2) are completed for use in CRSwNP (ClinicalTrials.gov identifier NCT02170337) and are under study in asthma (ClinicalTrials.gov identifier NCT03207243)<sup><a href="#ref-12">12</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d59526e303>Downstream (late) and adaptive immune pathways and potential targets</h2><p class="" id=d59526e306>Given the significant contribution of Th2-mediated inflammation in CRS, especially in eosinophilic CRS or CRSwNP, there is considerable potential for effective blockade of Th2 type cytokines directly to reduce the allergic inflammation. The “Th2-dependent” inflammatory subtype of asthma or CRS is mediated to a large extent by IL-4, IL-5, and IL-13 cytokines. A number of novel therapies are geared toward specific cytokine blockade for IL-4, IL-5, and IL-13. The role of IL-5, eosinophil inflammation, and pathology of CRSwNP is well known<sup><a href="#ref-25">25</a>–<a href="#ref-28">28</a></sup>. Mepolizumab, a monoclonal antibody against IL-5, has shown promise in the treatment of CRSwNP. Reduction in nasal polyp size was observed after two intravenous doses of 750 mg mepolizumab 28 days apart<sup><a href="#ref-29">29</a></sup>. It is worth mentioning that currently mepolizumab is FDA-approved for treatment of severe asthma with an underlying eosinophilic phenotype (eosinophil count greater than 300 cells/mm<sup>3</sup>) but at doses substantially smaller (100 mg) than what clinical studies have typically used. Other biologicals such as reslizumab (anti-IL-5) or benralizumab (anti-IL-5R) that inhibit IL-5 signaling would also be of theoretical benefit due to their ability to inhibit eosinophilic inflammation. Both Reslizumab and more recently Benralizumab are FDA-approved for the treatment of eosinophil-predominant asthma. Reslizumab was shown to improve asthma control in patients with nasal polyps<sup><a href="#ref-30">30</a></sup>. A pooled analysis of two reslizumab studies (ClinicalTrials.gov identifiers NCT01287039 and NCT01285323) demonstrated that, patients CRSwNP, had a 83% reduction in the annual rate of asthma exacerbations compared to those receiving reslizumab superior compared with the placebo group<sup><a href="#ref-31">31</a></sup>. The greater benefit of reslizumab in patients with comorbid asthma and CRSwNP suggests its utility in those with eosinophilic sinus disease, although studies targeting patients with CRS alone are not yet available. Benralizumab via its effect on IL-5R not only is thought to modulate eosinophilopoesis and eosinophil trafficking but also is reported to induce eosinophil apoptosis by antibody-dependent cell-mediated cytotoxicity<sup><a href="#ref-32">32</a></sup>. The anti-IL-5R effect could connote apoptosis to other IL-5R-containing cells such as basophils as well<sup><a href="#ref-33">33</a></sup>. A study of benralizumab in eosinophilic CRSwNP is ongoing (ClinicalTrials.gov identifier NCT02772419)<sup><a href="#ref-12">12</a></sup>.</p><p class="" id=d59526e344>IL-13 has long been thought to have pleiotropic effects in immune pathology in asthma, and its role in CRS, including induction of goblet hyperplasia, epithelial mesenchymal transformation, fibrosis, affecting tight junction formation and chemokine induction, may be similar<sup><a href="#ref-34">34</a>,<a href="#ref-35">35</a></sup>. IL-13 may be a potential target in CRS because of its effects on tissue remodeling and involvement in Th2 type inflammation. In asthma, a phase 2b randomized controlled trial with 300 mg tralokinumab provided every 2 weeks to severe asthmatics showed improvement in spirometric performance as measured by pre-bronchodilator forced expiratory volume in 1 second (FEV1) but failed to demonstrate clinical improvement in asthma exacerbation rates<sup><a href="#ref-36">36</a></sup>. Asthmatic patients on lebrikizumab, another anti-IL-13 monoclonal antibody, demonstrated an increase in FEV1 post-intervention which was especially marked in the subgroup that also had higher levels of serum periostin<sup><a href="#ref-37">37</a></sup>. That this connection between the efficacy of IL-13 blockade in a group of asthmatic patients with high serum periostin was replicated indicates a potential role of this biomarker for the identification of patients who may be responsive to IL-13 blockade<sup><a href="#ref-38">38</a></sup>. Serum periostin is also associated with CRSwNP along with IgE and anti-staphylococcal IgE<sup><a href="#ref-39">39</a></sup>, CRS with co-morbid asthma<sup><a href="#ref-40">40</a></sup>, and AERD<sup><a href="#ref-41">41</a></sup>. Although the value of this biomarker in the diagnosis of these clinically well-defined scenarios may be limited, it may be far more useful as a predictor of favorable response to IL-13 pathway inhibition. Additional trials with drugs blocking the interaction of IL-13 with IL-13 alpha 1 and alpha 2 receptors are in development<sup><a href="#ref-12">12</a></sup>. Dupilumab, a monoclonal antibody directed against the IL-4R alpha chain, affects function of both IL-13 and IL-4. The IL-4R alpha subunit along with the common gamma chain is part of the IL-4 receptor and, in conjunction with IL-13Rα1, forms a heteroreceptor that can bind to IL-4 or IL-13. Thus, this molecule has robust inhibitory activity on both IL-4 and IL-13 pathways affecting Th2 differentiation, IgE production<sup><a href="#ref-42">42</a></sup>, tissue remodeling, and other effects of both cytokines. Dupilumab has been shown to be effective in treating atopic Th2-driven conditions such as asthma and atopic dermatitis and is FDA-approved for use in the latter condition at the time of this writing<sup><a href="#ref-42">42</a>–<a href="#ref-44">44</a></sup>. More importantly, it has also shown promising therapeutic effects in CRSwNP in symptomatic patients refractory to intranasal corticosteroids<sup><a href="#ref-45">45</a></sup>. There are two FDA-approved agents that block IL-17 and are used in advanced management of psoriasis<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. Increasing evidence points to the role of IL-17 in asthma, especially the non-eosinophilic variants<sup><a href="#ref-48">48</a></sup>. The involvement of IL-17 (and IL-22) in some of the subtypes of CRS (both IL-5-negative and IL-5-high groups) suggests the potential applicability of specific use of these agents in specific subgroups<sup><a href="#ref-49">49</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d59526e417>Discussion</h2><p class="" id=d59526e420>As of submission of this article, no biologic therapy is FDA-approved for use in CRS. However, a number of biological therapies directed to cytokines that are key mediators in CRS inflammatory pathways are currently on the market. The US FDA has approved drugs for asthma (anti-IL-5 agents, including mepolizumab, reslizumab, benralizumab, and anti-IgE omalizumab); atopic dermatitis (anti-IL-4/IL-13 agent dupilumab), psoriasis (anti-IL-17 secukinumab and brodalumab), and chronic urticaria (anti-IgE and omalizumab). In the future, several biologics may be available for potential therapy of recalcritrant CRS. Additional focus of studies should address how these biologics will fit in contemporary use when compared with current standards of care (medical and surgical). Also, the long-term efficacy, safety, and cost-effectiveness of biologics will need to be compared with standard of care. The risk-benefit profile and cost-effectiveness of biologic therapy may be favorable in patients with truly recalcitrant CRS. At this time, it is not possible to predicate or predict whether, in the future, CRS patients such as those with eosinophilic disease will all receive anti-IL-5 therapy. In the case of patients with asthma, biologic therapy has been indicated for use in patients who have failed standard-of-care medical therapy and who meet requirements such as a threshold eosinophil level, presence of atopic sensitization, or serum IgE levels<sup><a href="#ref-50">50</a></sup>. It is likely that such an approach may be used for CRS where biologic therapy may be offered to patients with recalcitrant disease that has not responded to conventional medical and surgical therapy. Our current challenge is in identifying these subjects. Sophisticated endotyping in the clinical realm will be necessary to identify specific inflammatory mediators to target therapy, as is done in asthma.</p><p class="" id=d59526e427>A large majority of patients are responsive to conventional therapies, but some CRS patients do have recalcitrant disease. The role of such biological therapies must be placed in the context of currently utilized and relatively inexpensive medical therapies for CRS, such as intranasal corticosteroids and saline irrigation, as well as endoscopic sinus surgery and the disease presentation. Recalcitrant CRS patients who show repeated failure to be controlled on standard medical and surgical interventions, and may be the most suitable candidates for trialing biological therapy after addressing issues of compliance and medication technique.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d59526e433>Conclusions</h2><p class="" id=d59526e436>The future of medical therapy for CRS is exciting, and a number of precise pathway inhibitors are under investigation. The application of these biologics would require accurate characterization of the underlying inflammatory disease pathways and endotyping of CRS<sup><a href="#ref-5">5</a></sup>. Multiple agents are on the horizon for management of Th2 type and eosinophil-driven CRS. However, based on the drugs in development and ongoing clinical trials, a relative paucity of novel agents for management of the non-polyp or non-eosinophilic variant of the disease is noted. Additional areas of clinical therapeutics may emerge with greater understanding of sino-nasal microbiome dysbiosis as an evolving focus of investigation in the pathogenesis of CRS both with and without nasal polyposis<sup><a href="#ref-51">51</a>–<a href="#ref-54">54</a></sup>. The role and mechanism of microbes in epithelial barrier disruption and a maladaptive immune response are being elucidated<sup><a href="#ref-35">35</a>,<a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup>, and potential newer targets are being identified<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>. As these mechanisms are better understood, the application of biologic therapy may become available for all types of CRS, including non-polyp or non-eosinophilic variants.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d59526e471>Abbreviations</h2><p class="" id=d59526e474>AERD, aspirin exacerbated respiratory disease; CRS, chronic rhinosinusitis; CRSwNP, chronic rhinosinusitis with nasal polyps; FDA, US Food and Drug Administration; FEV1, forced expiratory volume in 1 second; IL, interleukin; ILC2, innate lymphoid cell type 2; Th2, type 2 helper; TSLP, thymic stromal lymphopoietin.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d59526e1 class=n-a></a><h2 class=main-title id=d59696>Competing interests</h2><p class=metadata-entry><a name=d59526e96 class=n-a></a><p id=d59526e97> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d59526e1 class=n-a></a><h2 class=main-title id=d59698>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d59526e481 class=n-a></a><h2 class=main-title id=d59526e483>Author information</h2><p class="" id=d59526e486>RD (MBBS, PhD) is a Consultant and Assistant Professor at the Division of Allergic Diseases, Mayo Clinic, Rochester, USA.</p><p class="" id=d59526e489>DL (MD) is a Consultant and Associate Professor at the Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Arizona, USA.</p></div><div class=back-section><a name=d59526e493 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d59892>References</h2><div class="section ref-list"><a name=d59526e493 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726155859"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e500 class=n-a></a>Orlandi RR, Kingdom TT, Hwang PH, <i> et al.</i>: International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. <i>Int Forum Allergy Rhinol.</i> 2016; <b>6 Suppl 1</b>: S22–209. <a target=xrefwindow id=d59526e511 href="http://www.ncbi.nlm.nih.gov/pubmed/26889651">PubMed Abstract </a> | <a target=xrefwindow id=d59526e514 href="http://dx.doi.org/10.1002/alr.21695">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726155859">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726620128"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e527 class=n-a></a>Stokes JR, Casale TB: Characterization of asthma endotypes: implications for therapy. <i>Ann Allergy Asthma Immunol.</i> 2016; <b>117</b>(2): 121–5. <a target=xrefwindow id=d59526e535 href="http://www.ncbi.nlm.nih.gov/pubmed/27499539">PubMed Abstract </a> | <a target=xrefwindow id=d59526e538 href="http://dx.doi.org/10.1016/j.anai.2016.05.016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726620128">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d59526e551 class=n-a></a>Fajt ML, Wenzel SE: Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. <i>J Allergy Clin Immunol.</i> 2015; <b>135</b>(2): 299–310; quiz 311. <a target=xrefwindow id=d59526e559 href="http://www.ncbi.nlm.nih.gov/pubmed/25662302">PubMed Abstract </a> | <a target=xrefwindow id=d59526e562 href="http://dx.doi.org/10.1016/j.jaci.2014.12.1871">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726491568"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e571 class=n-a></a>Bachert C, Akdis CA: Phenotypes and Emerging Endotypes of Chronic Rhinosinusitis. <i>J Allergy Clin Immunol Pract.</i> 2016; <b>4</b>(4): 621–8. <a target=xrefwindow id=d59526e579 href="http://www.ncbi.nlm.nih.gov/pubmed/27393777">PubMed Abstract </a> | <a target=xrefwindow id=d59526e582 href="http://dx.doi.org/10.1016/j.jaip.2016.05.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726491568">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d59526e595 class=n-a></a>Divekar R, Rank M, Squillace D, <i> et al.</i>: Unsupervised network mapping of commercially available immunoassay yields three distinct chronic rhinosinusitis endotypes. <i>Int Forum Allergy Rhinol.</i> 2017; <b>7</b>(4): 373–9. <a target=xrefwindow id=d59526e606 href="http://www.ncbi.nlm.nih.gov/pubmed/28042687">PubMed Abstract </a> | <a target=xrefwindow id=d59526e609 href="http://dx.doi.org/10.1002/alr.21904">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d59526e619 class=n-a></a>Divekar R, Kita H: Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. <i>Curr Opin Allergy Clin Immunol.</i> 2015; <b>15</b>(1): 98–103. <a target=xrefwindow id=d59526e627 href="http://www.ncbi.nlm.nih.gov/pubmed/25479313">PubMed Abstract </a> | <a target=xrefwindow id=d59526e630 href="http://dx.doi.org/10.1097/ACI.0000000000000133">Publisher Full Text </a> | <a target=xrefwindow id=d59526e633 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4346181">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724192038"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e642 class=n-a></a>Moussion C, Ortega N, Girard JP: The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells <i>in vivo</i>: a novel 'alarmin'? <i>PLoS One.</i> 2008; <b>3</b>(10): e3331. <a target=xrefwindow id=d59526e653 href="http://www.ncbi.nlm.nih.gov/pubmed/18836528">PubMed Abstract </a> | <a target=xrefwindow id=d59526e656 href="http://dx.doi.org/10.1371/journal.pone.0003331">Publisher Full Text </a> | <a target=xrefwindow id=d59526e660 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2556082">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724192038">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d59526e673 class=n-a></a>Miljkovic D, Bassiouni A, Cooksley C, <i> et al.</i>: Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis. <i>Allergy.</i> 2014; <b>69</b>(9): 1154–61. <a target=xrefwindow id=d59526e684 href="http://www.ncbi.nlm.nih.gov/pubmed/24924975">PubMed Abstract </a> | <a target=xrefwindow id=d59526e687 href="http://dx.doi.org/10.1111/all.12440">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d59526e696 class=n-a></a>Kato A: Immunopathology of chronic rhinosinusitis. <i>Allergol Int.</i> 2015; <b>64</b>(2): 121–30. <a target=xrefwindow id=d59526e704 href="http://www.ncbi.nlm.nih.gov/pubmed/25838086">PubMed Abstract </a> | <a target=xrefwindow id=d59526e707 href="http://dx.doi.org/10.1016/j.alit.2014.12.006">Publisher Full Text </a> | <a target=xrefwindow id=d59526e710 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4675657">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726033010"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e719 class=n-a></a>Buchheit KM, Cahill KN, Katz HR, <i> et al.</i>: Thymic stromal lymphopoietin controls prostaglandin D<sub>2</sub> generation in patients with aspirin-exacerbated respiratory disease. <i>J Allergy Clin Immunol.</i> 2016; <b>137</b>(5): 1566–1576.e5. <a target=xrefwindow id=d59526e733 href="http://www.ncbi.nlm.nih.gov/pubmed/26691435">PubMed Abstract </a> | <a target=xrefwindow id=d59526e737 href="http://dx.doi.org/10.1016/j.jaci.2015.10.020">Publisher Full Text </a> | <a target=xrefwindow id=d59526e740 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4860132">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726033010">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d59526e753 class=n-a></a>Liao B, Cao PP, Zeng M, <i> et al.</i>: Interaction of thymic stromal lymphopoietin, IL-33, and their receptors in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps. <i>Allergy.</i> 2015; <b>70</b>(9): 1169–80. <a target=xrefwindow id=d59526e764 href="http://www.ncbi.nlm.nih.gov/pubmed/26095319">PubMed Abstract </a> | <a target=xrefwindow id=d59526e767 href="http://dx.doi.org/10.1111/all.12667">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d59526e777 class=n-a></a>ClinicalTrials.gov, 2017. [Online]. Accessed: 10/10/2017. <a target=xrefwindow id=d59526e779 href="https://clinicaltrials.gov/">Reference Source</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730845215"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e788 class=n-a></a>Corren J, Parnes JR, Wang L, <i> et al.</i>: Tezepelumab in Adults with Uncontrolled Asthma. <i>N Engl J Med.</i> 2017; <b>377</b>(10): 936–46. <a target=xrefwindow id=d59526e799 href="http://www.ncbi.nlm.nih.gov/pubmed/28877011">PubMed Abstract </a> | <a target=xrefwindow id=d59526e802 href="http://dx.doi.org/10.1056/NEJMoa1704064">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730845215">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727763855"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e815 class=n-a></a>Drake LY, Kita H: IL-33: biological properties, functions, and roles in airway disease. <i>Immunol Rev.</i> 2017; <b>278</b>(1): 173–84. <a target=xrefwindow id=d59526e823 href="http://www.ncbi.nlm.nih.gov/pubmed/28658560">PubMed Abstract </a> | <a target=xrefwindow id=d59526e826 href="http://dx.doi.org/10.1111/imr.12552">Publisher Full Text </a> | <a target=xrefwindow id=d59526e829 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5492954">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727763855">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727097371"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e842 class=n-a></a>de Kleer IM, Kool M, de Bruijn MJ, <i> et al.</i>: Perinatal Activation of the Interleukin-33 Pathway Promotes Type 2 Immunity in the Developing Lung. <i>Immunity.</i> 2016; <b>45</b>(6): 1285–98. <a target=xrefwindow id=d59526e853 href="http://www.ncbi.nlm.nih.gov/pubmed/27939673">PubMed Abstract </a> | <a target=xrefwindow id=d59526e856 href="http://dx.doi.org/10.1016/j.immuni.2016.10.031">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727097371">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1029918"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e869 class=n-a></a>Schmitz J, Owyang A, Oldham E, <i> et al.</i>: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. <i>Immunity.</i> 2005; <b>23</b>(5): 479–90. <a target=xrefwindow id=d59526e880 href="http://www.ncbi.nlm.nih.gov/pubmed/16286016">PubMed Abstract </a> | <a target=xrefwindow id=d59526e883 href="http://dx.doi.org/10.1016/j.immuni.2005.09.015">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1029918">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d59526e896 class=n-a></a>Lam M, Hull L, Imrie A, <i> et al.</i>: Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis. <i>Am J Rhinol Allergy.</i> 2015; <b>29</b>(3): 175–81. <a target=xrefwindow id=d59526e907 href="http://www.ncbi.nlm.nih.gov/pubmed/25975248">PubMed Abstract </a> | <a target=xrefwindow id=d59526e910 href="http://dx.doi.org/10.2500/ajra.2015.29.4176">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d59526e920 class=n-a></a>Smithgall MD, Comeau BR, Yoon BP, <i> et al.</i>: IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. <i>Int Immunol.</i> 2008; <b>20</b>(8): 1019–30. <a target=xrefwindow id=d59526e931 href="http://www.ncbi.nlm.nih.gov/pubmed/18550585">PubMed Abstract </a> | <a target=xrefwindow id=d59526e934 href="http://dx.doi.org/10.1093/intimm/dxn060">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d59526e943 class=n-a></a>Shaw JL, Fakhri S, Citardi MJ, <i> et al.</i>: IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. <i>Am J Respir Crit Care Med.</i> 2013; <b>188</b>(4): 432–9. <a target=xrefwindow id=d59526e954 href="http://www.ncbi.nlm.nih.gov/pubmed/23805875">PubMed Abstract </a> | <a target=xrefwindow id=d59526e957 href="http://dx.doi.org/10.1164/rccm.201212-2227OC">Publisher Full Text </a> | <a target=xrefwindow id=d59526e961 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5448506">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d59526e970 class=n-a></a>Allakhverdi Z, Smith DE, Comeau MR, <i> et al.</i>: Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. <i>J Immunol.</i> 2007; <b>179</b>(4): 2051–4. <a target=xrefwindow id=d59526e981 href="http://www.ncbi.nlm.nih.gov/pubmed/17675461">PubMed Abstract </a> | <a target=xrefwindow id=d59526e984 href="http://dx.doi.org/10.4049/jimmunol.179.4.2051">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d59526e993 class=n-a></a>Rank MA, Kobayashi T, Kozaki H, <i> et al.</i>: IL-33-activated dendritic cells induce an atypical TH2-type response. <i>J Allergy Clin Immunol.</i> 2009; <b>123</b>(5): 1047–54. <a target=xrefwindow id=d59526e1004 href="http://www.ncbi.nlm.nih.gov/pubmed/19361843">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1007 href="http://dx.doi.org/10.1016/j.jaci.2009.02.026">Publisher Full Text </a> | <a target=xrefwindow id=d59526e1011 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2711963">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d59526e1020 class=n-a></a>Cherry WB, Yoon J, Bartemes KR, <i> et al.</i>: A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. <i>J Allergy Clin Immunol.</i> 2008; <b>121</b>(6): 1484–90. <a target=xrefwindow id=d59526e1031 href="http://www.ncbi.nlm.nih.gov/pubmed/18539196">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1034 href="http://dx.doi.org/10.1016/j.jaci.2008.04.005">Publisher Full Text </a> | <a target=xrefwindow id=d59526e1038 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2821937">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727022415"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1047 class=n-a></a>Kim DK, Jin HR, Eun KM, <i> et al.</i>: The role of interleukin-33 in chronic rhinosinusitis. <i>Thorax.</i> 2017; <b>72</b>(7): 635–45. <a target=xrefwindow id=d59526e1058 href="http://www.ncbi.nlm.nih.gov/pubmed/27885166">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1061 href="http://dx.doi.org/10.1136/thoraxjnl-2016-208772">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727022415">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d59526e1075 class=n-a></a>Bachert C, Zhang N, Patou J, <i> et al.</i>: Role of staphylococcal superantigens in upper airway disease. <i>Curr Opin Allergy Clin Immunol.</i> 2008; <b>8</b>(1): 34–8. <a target=xrefwindow id=d59526e1086 href="http://www.ncbi.nlm.nih.gov/pubmed/18188015">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1089 href="http://dx.doi.org/10.1097/ACI.0b013e3282f4178f">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d59526e1098 class=n-a></a>Gevaert P, Lang-Loidolt D, Lackner A, <i> et al.</i>: Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. <i>J Allergy Clin Immunol.</i> 2006; <b>118</b>(5): 1133–41. <a target=xrefwindow id=d59526e1109 href="http://www.ncbi.nlm.nih.gov/pubmed/17088140">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1112 href="http://dx.doi.org/10.1016/j.jaci.2006.05.031">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d59526e1121 class=n-a></a>Hamilos DL, Leung DY, Huston DP, <i> et al.</i>: GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). <i>Clin Exp Allergy.</i> 1998; <b>28</b>(9): 1145–52. <a target=xrefwindow id=d59526e1132 href="http://www.ncbi.nlm.nih.gov/pubmed/9761019">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1135 href="http://dx.doi.org/10.1046/j.1365-2222.1998.00380.x">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d59526e1144 class=n-a></a>Bachert C, Wagenmann M, Hauser U, <i> et al.</i>: IL-5 synthesis is upregulated in human nasal polyp tissue. <i>J Allergy Clin Immunol.</i> 1997; <b>99</b>(6 Pt 1): 837–42. <a target=xrefwindow id=d59526e1155 href="http://www.ncbi.nlm.nih.gov/pubmed/9215253">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1158 href="http://dx.doi.org/10.1016/S0091-6749(97)80019-X">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d59526e1167 class=n-a></a>van Crombruggen K, Zhang N, Gevaert P, <i> et al.</i>: Pathogenesis of chronic rhinosinusitis: inflammation. <i>J Allergy Clin Immunol.</i> 2011; <b>128</b>(4): 728–32. <a target=xrefwindow id=d59526e1178 href="http://www.ncbi.nlm.nih.gov/pubmed/21868076">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1181 href="http://dx.doi.org/10.1016/j.jaci.2011.07.049">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13581956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1190 class=n-a></a>Gevaert P, Van Bruaene N, Cattaert T, <i> et al.</i>: Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. <i>J Allergy Clin Immunol.</i> 2011; <b>128</b>(5): 989–95.e1–8. <a target=xrefwindow id=d59526e1201 href="http://www.ncbi.nlm.nih.gov/pubmed/21958585">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1204 href="http://dx.doi.org/10.1016/j.jaci.2011.07.056">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13581956">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13437011"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1218 class=n-a></a>Castro M, Mathur S, Hargreave F, <i> et al.</i>: Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. <i>Am J Respir Crit Care Med.</i> 2011; <b>184</b>(10): 1125–32. <a target=xrefwindow id=d59526e1229 href="http://www.ncbi.nlm.nih.gov/pubmed/21852542">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1232 href="http://dx.doi.org/10.1164/rccm.201103-0396OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13437011">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732835922"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1245 class=n-a></a>Weinstein SF, Germinaro M, Bardin P, <i> et al.</i>: Efficacy of Reslizumab with Asthma, Chronic Sinusitis with Nasal Polyps and Elevated Blood Eosinophils. <i>J Allergy Clin Immunol.</i> 2016; <b>137</b>(Supplement 2): AB86. <a target=xrefwindow id=d59526e1256 href="http://dx.doi.org/10.1016/j.jaci.2015.12.409">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732835922">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/3797966"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1269 class=n-a></a>Kolbeck R, Kozhich A, Koike M, <i> et al.</i>: MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. <i>J Allergy Clin Immunol.</i> 2010; <b>125</b>(6): 1344–1353.e2. <a target=xrefwindow id=d59526e1280 href="http://www.ncbi.nlm.nih.gov/pubmed/20513525">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1283 href="http://dx.doi.org/10.1016/j.jaci.2010.04.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/3797966">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d59526e1296 class=n-a></a>Laviolette M, Gossage DL, Gauvreau G, <i> et al.</i>: Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. <i>J Allergy Clin Immunol.</i> 2013; <b>132</b>(5): 1086–1096.e5. <a target=xrefwindow id=d59526e1307 href="http://www.ncbi.nlm.nih.gov/pubmed/23866823">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1310 href="http://dx.doi.org/10.1016/j.jaci.2013.05.020">Publisher Full Text </a> | <a target=xrefwindow id=d59526e1314 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4172321">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d59526e1323 class=n-a></a>Hulse KE, Stevens WW, Tan BK, <i> et al.</i>: Pathogenesis of nasal polyposis. <i>Clin Exp Allergy.</i> 2015; <b>45</b>(2): 328–46. <a target=xrefwindow id=d59526e1334 href="http://www.ncbi.nlm.nih.gov/pubmed/25482020">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1337 href="http://dx.doi.org/10.1111/cea.12472">Publisher Full Text </a> | <a target=xrefwindow id=d59526e1341 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4422388">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727104855"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1350 class=n-a></a>Schleimer RP: Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis. <i>Annu Rev Pathol.</i> 2017; <b>12</b>: 331–57. <a target=xrefwindow id=d59526e1358 href="http://www.ncbi.nlm.nih.gov/pubmed/27959637">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1361 href="http://dx.doi.org/10.1146/annurev-pathol-052016-100401">Publisher Full Text </a> | <a target=xrefwindow id=d59526e1364 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5514544">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727104855">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d59526e1378 class=n-a></a>Brightling CE, Chanez P, Leigh R, <i> et al.</i>: Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial. <i>Lancet Respir Med.</i> 2015; <b>3</b>(9): 692–701. <a target=xrefwindow id=d59526e1389 href="http://www.ncbi.nlm.nih.gov/pubmed/26231288">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1392 href="http://dx.doi.org/10.1016/S2213-2600(15)00197-6">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/12609956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1401 class=n-a></a>Corren J, Lemanske RF, Hanania NA, <i> et al.</i>: Lebrikizumab treatment in adults with asthma. <i>N Engl J Med.</i> 2011; <b>365</b>(12): 1088–98. <a target=xrefwindow id=d59526e1412 href="http://www.ncbi.nlm.nih.gov/pubmed/21812663">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1415 href="http://dx.doi.org/10.1056/NEJMoa1106469">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/12609956">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725511220"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1428 class=n-a></a>Hanania NA, Noonan M, Corren J, <i> et al.</i>: Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. <i>Thorax.</i> 2015; <b>70</b>(8): 748–56. <a target=xrefwindow id=d59526e1439 href="http://www.ncbi.nlm.nih.gov/pubmed/26001563">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1442 href="http://dx.doi.org/10.1136/thoraxjnl-2014-206719">Publisher Full Text </a> | <a target=xrefwindow id=d59526e1446 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4515999">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725511220">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731981236"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1459 class=n-a></a>Jonstam K, Westman M, Holtappels G, <i> et al.</i>: Serum periostin, IgE, and SE-IgE can be used as biomarkers to identify moderate to severe chronic rhinosinusitis with nasal polyps. <i>J Allergy Clin Immunol.</i> 2017; <b>140</b>(6): 1705–1708.e3. <a target=xrefwindow id=d59526e1470 href="http://www.ncbi.nlm.nih.gov/pubmed/28870464">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1473 href="http://dx.doi.org/10.1016/j.jaci.2017.07.031">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731981236">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727362167"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1486 class=n-a></a>Asano T, Kanemitsu Y, Takemura M, <i> et al.</i>: Serum Periostin as a Biomarker for Comorbid Chronic Rhinosinusitis in Patients with Asthma. <i>Ann Am Thorac Soc.</i> 2017; <b>14</b>(5): 667–75. <a target=xrefwindow id=d59526e1497 href="http://www.ncbi.nlm.nih.gov/pubmed/28248547">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1500 href="http://dx.doi.org/10.1513/AnnalsATS.201609-720OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727362167">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d59526e1513 class=n-a></a>Kim MA, Izuhara K, Ohta S, <i> et al.</i>: Association of serum periostin with aspirin-exacerbated respiratory disease. <i>Ann Allergy Asthma Immunol.</i> 2014; <b>113</b>(3): 314–20. <a target=xrefwindow id=d59526e1524 href="http://www.ncbi.nlm.nih.gov/pubmed/25037608">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1527 href="http://dx.doi.org/10.1016/j.anai.2014.06.014">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718011925"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1537 class=n-a></a>Wenzel S, Ford L, Pearlman D, <i> et al.</i>: Dupilumab in persistent asthma with elevated eosinophil levels. <i>N Engl J Med.</i> 2013; <b>368</b>(26): 2455–66. <a target=xrefwindow id=d59526e1548 href="http://www.ncbi.nlm.nih.gov/pubmed/23688323">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1551 href="http://dx.doi.org/10.1056/NEJMoa1304048">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718011925">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726323110"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1564 class=n-a></a>Wenzel S, Castro M, Corren J, <i> et al.</i>: Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. <i>Lancet.</i> 2016; <b>388</b>(10039): 31–44. <a target=xrefwindow id=d59526e1575 href="http://www.ncbi.nlm.nih.gov/pubmed/27130691">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1578 href="http://dx.doi.org/10.1016/S0140-6736(16)30307-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726323110">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718485867"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1591 class=n-a></a>Beck LA, Thaçi D, Hamilton JD, <i> et al.</i>: Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. <i>N Engl J Med.</i> 2014; <b>371</b>(2): 130–9. <a target=xrefwindow id=d59526e1602 href="http://www.ncbi.nlm.nih.gov/pubmed/25006719">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1605 href="http://dx.doi.org/10.1056/NEJMoa1314768">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718485867">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726113355"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1618 class=n-a></a>Bachert C, Mannent L, Naclerio RM, <i> et al.</i>: Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial. <i>JAMA.</i> 2016; <b>315</b>(5): 469–79. <a target=xrefwindow id=d59526e1629 href="http://www.ncbi.nlm.nih.gov/pubmed/26836729">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1632 href="http://dx.doi.org/10.1001/jama.2015.19330">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726113355">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/14267068"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1645 class=n-a></a>Papp KA, Leonardi C, Menter A, <i> et al.</i>: Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. <i>N Engl J Med.</i> 2012; <b>366</b>(13): 1181–9. <a target=xrefwindow id=d59526e1656 href="http://www.ncbi.nlm.nih.gov/pubmed/22455412">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1659 href="http://dx.doi.org/10.1056/NEJMoa1109017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/14267068">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d59526e1672 class=n-a></a>Langley RG, Elewski BE, Lebwohl M, <i> et al.</i>: Secukinumab in plaque psoriasis--results of two phase 3 trials. <i>N Engl J Med.</i> 2014; <b>371</b>(4): 326–38. <a target=xrefwindow id=d59526e1683 href="http://www.ncbi.nlm.nih.gov/pubmed/25007392">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1686 href="http://dx.doi.org/10.1056/NEJMoa1314258">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d59526e1696 class=n-a></a>Chesné J, Braza F, Mahay G, <i> et al.</i>: IL-17 in severe asthma. Where do we stand? <i>Am J Respir Crit Care Med.</i> 2014; <b>190</b>(10): 1094–101. <a target=xrefwindow id=d59526e1707 href="http://www.ncbi.nlm.nih.gov/pubmed/25162311">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1710 href="http://dx.doi.org/10.1164/rccm.201405-0859PP">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726197752"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1719 class=n-a></a>Tomassen P, Vandeplas G, Van Zele T, <i> et al.</i>: Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. <i>J Allergy Clin Immunol.</i> 2016; <b>137</b>(5): 1449–1456.e4. <a target=xrefwindow id=d59526e1730 href="http://www.ncbi.nlm.nih.gov/pubmed/26949058">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1733 href="http://dx.doi.org/10.1016/j.jaci.2015.12.1324">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726197752">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d59526e1746 class=n-a></a>Darveaux J, Busse WW: Biologics in asthma--the next step toward personalized treatment. <i>J Allergy Clin Immunol Pract.</i> 2015; <b>3</b>(2): 152–60; quiz 161. <a target=xrefwindow id=d59526e1754 href="http://www.ncbi.nlm.nih.gov/pubmed/25754716">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1757 href="http://dx.doi.org/10.1016/j.jaip.2014.09.014">Publisher Full Text </a> | <a target=xrefwindow id=d59526e1760 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4774509">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d59526e1769 class=n-a></a>Lal D, Keim P, Delisle J, <i> et al.</i>: Mapping and comparing bacterial microbiota in the sinonasal cavity of healthy, allergic rhinitis, and chronic rhinosinusitis subjects. <i>Int Forum Allergy Rhinol.</i> 2017; <b>7</b>(6): 561–9. <a target=xrefwindow id=d59526e1780 href="http://www.ncbi.nlm.nih.gov/pubmed/28481057">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1783 href="http://dx.doi.org/10.1002/alr.21934">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d59526e1792 class=n-a></a>Cope EK, Lynch SV: Novel microbiome-based therapeutics for chronic rhinosinusitis. <i>Curr Allergy Asthma Rep.</i> 2015; <b>15</b>(3): 504. <a target=xrefwindow id=d59526e1800 href="http://www.ncbi.nlm.nih.gov/pubmed/25777787">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1803 href="http://dx.doi.org/10.1007/s11882-014-0504-y">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717963943"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1812 class=n-a></a>Abreu NA, Nagalingam NA, Song Y, <i> et al.</i>: Sinus microbiome diversity depletion and <i>Corynebacterium tuberculostearicum</i> enrichment mediates rhinosinusitis. <i>Sci Transl Med.</i> 2012; <b>4</b>(151): 151ra124. <a target=xrefwindow id=d59526e1826 href="http://www.ncbi.nlm.nih.gov/pubmed/22972842">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1830 href="http://dx.doi.org/10.1126/scitranslmed.3003783">Publisher Full Text </a> | <a target=xrefwindow id=d59526e1833 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4786373">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717963943">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d59526e1847 class=n-a></a>Ramakrishnan VR, Hauser LJ, Feazel LM, <i> et al.</i>: Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome. <i>J Allergy Clin Immunol.</i> 2015; <b>136</b>(2): 334–42.e1. <a target=xrefwindow id=d59526e1858 href="http://www.ncbi.nlm.nih.gov/pubmed/25819063">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1861 href="http://dx.doi.org/10.1016/j.jaci.2015.02.008">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d59526e1870 class=n-a></a>Tieu DD, Kern RC, Schleimer RP: Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. <i>J Allergy Clin Immunol.</i> 2009; <b>124</b>(1): 37–42. <a target=xrefwindow id=d59526e1878 href="http://www.ncbi.nlm.nih.gov/pubmed/19560577">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1881 href="http://dx.doi.org/10.1016/j.jaci.2009.04.045">Publisher Full Text </a> | <a target=xrefwindow id=d59526e1884 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2802265">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation> <a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727690385"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a> <a name=d59526e1893 class=n-a></a>Schleimer RP, Berdnikovs S: Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases. <i>J Allergy Clin Immunol.</i> 2017; <b>139</b>(6): 1752–61. <a target=xrefwindow id=d59526e1901 href="http://www.ncbi.nlm.nih.gov/pubmed/28583447">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1904 href="http://dx.doi.org/10.1016/j.jaci.2017.04.010">Publisher Full Text </a> | <a target=xrefwindow id=d59526e1907 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5753806">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727690385">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726445988"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1923 class=n-a></a>Steelant B, Seys SF, Boeckxstaens G, <i> et al.</i>: Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease. <i>Rhinology.</i> 2016; <b>54</b>(3): 195–205. <a target=xrefwindow id=d59526e1934 href="http://www.ncbi.nlm.nih.gov/pubmed/27316042">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726445988">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725421418"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d59526e1947 class=n-a></a>Pothoven KL, Norton JE, Hulse KE, <i> et al.</i>: Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease. <i>J Allergy Clin Immunol.</i> 2015; <b>136</b>(3): 737–746.e4. <a target=xrefwindow id=d59526e1958 href="http://www.ncbi.nlm.nih.gov/pubmed/25840724">PubMed Abstract </a> | <a target=xrefwindow id=d59526e1961 href="http://dx.doi.org/10.1016/j.jaci.2015.01.043">Publisher Full Text </a> | <a target=xrefwindow id=d59526e1965 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4562861">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725421418">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Mar 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-412.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-412.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Allergic Diseases, Mayo Clinic, Rochester, USA<br/> <sup>2</sup> Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Arizona, USA<br/> <p> <div class=margin-bottom> Rohit Divekar <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Devyani Lal <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-412/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 29 Mar 2018, 7:412 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.13170.1">https://doi.org/10.12688/f1000research.13170.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Divekar R and Lal D. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=14286 data-id=13170 data-downloads="" data-views="" data-scholar="10.12688/f1000research.13170.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-412/v1/pdf?article_uuid=08d2aadd-c966-4996-aa28-08a9962a524c" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.13170.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Divekar R and Lal D. Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):412 (<a href="https://doi.org/10.12688/f1000research.13170.1" target=_blank>https://doi.org/10.12688/f1000research.13170.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=13170 id=mobile-track-article-signin-13170 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/13170?target=/articles/7-412.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=14286 /> <input name=articleId type=hidden value=13170 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Spencer Payne</strong>, Department of Otolaryngology Head & Neck Surgery, University of Virginia Health System, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Ahmad Sedaghat</strong>, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, USA; Department of Otolaryngology, Harvard Medical School, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Mar 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-412.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-412.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=31919-32045></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=31918-32044></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-412/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>29 Mar 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Spencer Payne</strong>, Department of Otolaryngology Head & Neck Surgery, University of Virginia Health System, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Ahmad Sedaghat</strong>, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, USA; Department of Otolaryngology, Harvard Medical School, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-412.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-412/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in biologic therapy of asthma...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-412/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-412/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-412/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Divekar R and Lal D');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-412/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-412",
            templates : {
                twitter : "Recent advances in biologic therapy of asthma and the role in.... Divekar R and Lal D, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-412/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/13170/14286")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "14286");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "32044": 0,
                           "32045": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "e94e37d6-3823-4685-9d19-ed338d3bbd21";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-412.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-412.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-412.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-412.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-412.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>